This Week in Cardiology

• Dec 20 2024 This Week in Cardiology   Listener feedback, multiple studies in AF ablation, a DANISH trial substudy of ICDs in NICM, and more data on eye complications of GLP-1 agonists are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, December 20, 2024
• Dec 13 2024 This Week in Cardiology   US doc's pay, the ticagrelor controversy and new RCTs, clopidogrel beats ASA, holding antiplatelets for non-cardiac surgery, and Prof Cleland and ASA dogma are the topics John Mandrola, MD, covers this week.
  theheart.org on Medscape, December 13, 2024
• Dec 06 2024 This Week in Cardiology   Tirzepatide vs semaglutide in obesity; GLP1a use is complicated; HF outcomes; the misuse of meta-analyses in HF; and a breakthrough in HF care are the topics John Mandrola, MD, covers this week.
  theheart.org on Medscape, December 06, 2024
• Nov 22 2024 This Week in Cardiology   An AHA review: the OPTION, SUMMIT, VANISH 2, SARAH, and CLEAR trials are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, November 22, 2024
• Nov 15 2024 This Week in Cardiology   Tirzepatide, AF screening, and an AHA preview, including VT ablation, LAAC at the time of AF ablation, BP targets, and GLP1 agonists in HF are the topics John Mandrola, MD, covers in today's podcast.
  theheart.org on Medscape, November 15, 2024
• Nov 08 2024 This Week in Cardiology   The EARLY TAVR trial, colchicine after MI, and the TRISCEND II trial of tricuspid valve replacement are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, November 08, 2024
• Oct 25 2024 This Week in Cardiology   Listener feedback on PFA and STEMI/NSTEMI paradigm, oral semaglutide, symptomatic vs asymptomatic AF, and the win-ratio are the topics John Mandrola, MD, discusses in this week's podcast.
  theheart.org on Medscape, October 25, 2024
• Oct 18 2024 This Week in Cardiology   Listener feedback on the c-statistic, atherosclerotic plaque imaging, WATCHMAN implant decisions in the US, and deprescribing are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, October 18, 2024
• Oct 11 2024 This Week in Cardiology   Reader feedback on cardiac devices and PFA, a new paradigm in the language of MI, sudden cardiac death, and measuring blood pressure are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, October 11, 2024
• Oct 04 2024 This Week in Cardiology   Reader feedback on LGE pre-ICDs, PFA for AF ablation, CTO-PCI, endovascular ablation of the greater splanchnic nerve in HFpEF, and data sharing are the topics John Mandrola, MD, covers this week.
  theheart.org on Medscape, October 04, 2024
• Sep 27 2024 This Week in Cardiology   Surgical clearance, NICM assessment, dueling perspectives on PCI as first-line therapy for angina, GDMT in HFrEF are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, September 27, 2024
• Sep 20 2024 This Week in Cardiology   Listener feedback, K levels post cardiac surgery, cardiac device safety, disparities in preventive care, stopping trials early, and a SHAM-PVI update are the topics John Mandrola, MD, covers this week.
  theheart.org on Medscape, September 20, 2024
• Sep 13 2024 This Week in Cardiology   More from ESC: the SCOFF trial and fasting before cardiac cath, MATTERHORN, humbling data with AI, plus a reflection on the work of being a patient are the topics John Mandrola, MD, covers this week.
  theheart.org on Medscape, September 13, 2024
• Sep 06 2024 This Week in Cardiology   Feedback on ABYSS and beta-blockers, more ESC recap, including SHAM-PVI, FINEARTS-HF, and RESHAPE HF2 trials are the topics John Mandrola, MD, discusses in today’s podcast.
  theheart.org on Medscape, September 06, 2024
• Aug 30 2024 This Week in Cardiology   From ESC: post-MI beta blockers, a new therapy for ATTR-CM, holding RASi before non-cardiac surgery, good news in HFpEF, and an ESC preview are the topics John Mandrola, MD, covers this week.
  theheart.org on Medscape, August 30, 2024
• Aug 23 2024 This Week in Cardiology   Suicidal ideation and GLP-1 agonists, a repeat of PARADIGM HF in Chagas CM, CASTLE HTx critical appraisal, and primary prevention of SCD in HF are the topics John Mandrola, MD, covers this week.
  theheart.org on Medscape, August 23, 2024
• Aug 16 2024 This Week in Cardiology   Diuretic therapy in HFrEF, AF ablation, TACT 2 and the story of subgroups, and SGLT2 inhibitor underuse are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, August 16, 2024
• Aug 09 2024 This Week in Cardiology   Prediction models vs clinical judgement, CCTA quantification of atherosclerosis, AF ablation plus LAAO, atrial shunt devices, and HF medical therapy are topics John Mandrola, MD, covers this week.
  theheart.org on Medscape, August 09, 2024
• Aug 02 2024 This Week in Cardiology   Two downsides of PFA including autonomic tone and hemolysis, a bad surrogate in AF care, and controversies in defining cardiac risk are the topics John Mandrola, MD, covers in this week's podcast.
  theheart.org on Medscape, August 02, 2024
• Jul 26 2024 This Week in Cardiology   Health and income, high BP in the hospital, and more on subclinical AF and when to use anticoagulants are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, July 26, 2024